Structure-based de novo design of novel inhibitors of the MDM2-p53 interaction

被引：0

作者：

Sun, Daqing ^{[1
]}

Rew, Yosup ^{[1
]}

De Turiso, Felix Gonzalez Lopez ^{[1
]}

Bartberger, Michael D. ^{[3
]}

Beck, Hilary P. ^{[1
]}

Canon, Jude ^{[4
]}

Chen, Ada ^{[1
]}

Chow, David ^{[1
]}

Deignan, Jeffrey ^{[1
]}

Fox, Brian M. ^{[1
]}

Huang, Xin ^{[5
]}

Jiang, Min ^{[2
]}

Jiao, Xianyun ^{[1
]}

Jin, Lixia ^{[2
]}

Kopecky, David J. ^{[1
]}

Li, Yihong ^{[1
]}

Lo, Mei-Chu ^{[1
]}

Long, Alexander M. ^{[5
]}

Michelsen, Klaus ^{[3
]}

Oliner, Jonathan D. ^{[4
]}

Osgood, Tao ^{[4
]}

Saiki, Anne Y. ^{[4
]}

Schneider, Steve ^{[5
]}

Yakowec, Peter ^{[5
]}

Yan, Xuelei ^{[1
]}

Ye, Qiuping ^{[2
]}

Yu, Dongyin ^{[4
]}

Zhao, Xiaoning ^{[1
]}

Zhou, Jing ^{[1
]}

Olson, Steven H. ^{[1
]}

Medina, Julio C. ^{[1
]}

机构：

[1] Amgen Inc, Therapeut Discovery, San Francisco, CA 94080 USA

[2] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA

[3] Amgen Inc, Therapeut Discovery, Thousand Oaks, CA 91320 USA

[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Therapeut Discovery, Cambridge, MA 02142 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[31] Small molecule inhibitors of the human MDM2-p53 interaction as anticancer agents
Wang, S.
Shangary, S.
Qin, Q.
McEachern, D.
Ding, K.
Nikolovska-Coleska, Z.
Lu, Y.
Malek, S.
Guo, M.
Yang, D.
EJC SUPPLEMENTS, 2008, 6 (12): : 83 - 83
[32] Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres
Gonzalez, Ana Z.
Li, Zhihong
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Duquette, Jason
Eksterowicz, John
Fox, Brian M.
Fu, Jiasheng
Huang, Xin
Houze, Jonathan
Jin, Lixia
Li, Yihong
Ling, Yun
Lo, Mei-Chu
Long, Alexander M.
McGee, Lawrence R.
McIntosh, Joel
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Wortman, Sarah
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Sun, Daqing
Medina, Julio C.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (07) : 2963 - 2988
[33] Targeting the MDM2-p53 interaction for cancer therapy
Shangary, Sanjeev
Wang, Shaomeng
CLINICAL CANCER RESEARCH, 2008, 14 (17) : 5318 - 5324
[34] Total Mutagenesis and the Effects on the MDM2-p53 Interaction
Beyer, George
Thayer, Kelly
FASEB JOURNAL, 2015, 29
[35] An X-ray crystal structure-based understanding of the inhibition of the MDM2-p53 protein-protein interaction by isoindolinones
Anil, B.
Blackburn, E.
Blackburn, T.
Cully, S.
Liu, J.
Drummond, C. J.
Endicott, J. A.
Golding, B. T.
Griffin, R. J.
Haggerty, K.
Lunec, J.
Newell, D. R.
Revill, C. H.
Riedinger, C.
Watson, A. F.
Xu, Q.
Zhao, Y.
Hardcastle, I. R.
Noble, M. E. M.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : 91 - 92
[36] Design and organocatalytic synthesis of spirooxindole-cyclopentene-isoxazole hybrids as novel MDM2-p53 inhibitors
Xie, Xin
Xiong, Shan-Shan
Li, Xiang
Huang, He
Wu, Feng-Bo
Shen, Peng-Fei
Peng, Cheng
He, Gu
Han, Bo
ORGANIC CHEMISTRY FRONTIERS, 2021, 8 (08): : 1836 - 1843
[37] Selective and Potent Morpholinone Inhibitors of the MDM2-p53 Protein-Protein Interaction
Gonzalez, Ana Z.
Eksterowicz, John
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Duquette, Jason
Fox, Brian M.
Fu, Jiasheng
Huang, Xin
Houze, Jonathan B.
Jin, Lixia
Li, Yihong
Li, Zhihong
Ling, Yun
Lo, Mei-Chu
Long, Alexander M.
McGee, Lawrence R.
McIntosh, Joel
McMinn, Dustin L.
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Wortman, Sarah
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Medina, Julio C.
Sun, Daqing
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2472 - 2488
[38] Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models
Bowman, Anna L.
Nikolovska-Coleska, Zaneta
Zhong, Haizhen
Wang, Shaomeng
Carlson, Heather A.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (42) : 12809 - 12814
[39] Structure-based de novo design of Eya2 phosphatase inhibitors
Park, Hwangseo
Ryu, Seong Eon
Kim, Seung Jun
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2012, 38 : 382 - 388
[40] An update patent review of MDM2-p53 interaction inhibitors (2019-2023)
Twarda-Clapa, Aleksandra
EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (12) : 1177 - 1198

← 1 2 3 4 5 →